Security
USPH · U S PHYSICAL THERAPY INC /NV
USPHNYSECommon stockCurrentCIK 885978Updated Sep 25, 2026
USPH price & chart
Loading TradingView…
NYSE:USPH on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other Events
Items 1.01, 5.02, 8.01, 9.01
SCHEDULE 13G/A filing
Regulation FD Disclosure
Items 7.01, 9.01
SCHEDULE 13G/A filing
Show 5 more recent filings
Regulation FD Disclosure
Items 7.01, 9.01
10-Q filing
Results of Operations and Financial Condition · Other Events
Items 2.02, 8.01, 9.01
SCHEDULE 13G/A filing
Other Events
Items 8.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 1,204,010,000Source | 1,167,467,000Source | 997,238,000Source | 858,154,000Source |
| Property, Plant and Equipment, NetUSD | 35,651,000Source | 32,140,000Source | 26,102,000Source | 24,748,000Source |
| GoodwillUSD | 692,392,000Source | 667,152,000Source | 509,571,000Source | 494,101,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 172,861,000Source | 179,311,000Source | 109,682,000Source | 108,755,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 35,570,000Source | 41,362,000Source | 152,825,000Source | 31,594,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 64,249,000Source | 59,040,000Source | 51,866,000Source | 51,934,000Source |
| Assets, CurrentUSD | 139,990,000Source | 137,583,000Source | 233,375,000Source | 111,266,000Source |
| Operating Lease, Right-of-Use AssetUSD | 144,197,000Source | 133,936,000Source | 103,431,000Source | 103,004,000Source |
| Other Assets, NoncurrentUSD | 6,644,000Source | 5,155,000Source | 2,821,000Source | 4,149,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 433,811,000Source | 408,421,000Source | 345,000,000Source | 373,586,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 174,000Source | 172,000Source | 172,000Source | 152,000Source |
| Additional Paid in CapitalUSD | 285,522,000Source | 290,321,000Source | 281,096,000Source | 110,317,000Source |
| Retained Earnings (Accumulated Deficit)USD | 227,216,000Source | 227,265,000Source | 223,772,000Source | 232,948,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 714,000Source | 2,799,000Source | 2,782,000Source | 4,004,000Source |
| Stockholders' Equity Attributable to ParentUSD | 476,432,000Source | 488,929,000Source | 476,194,000Source | 315,793,000Source |
| Liabilities and EquityUSD | 1,204,010,000Source | 1,167,467,000Source | 997,238,000Source | 858,154,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 139,040,000Source | 116,283,000Source | 102,185,000Source | 85,489,000Source |
| Operating Lease, Liability, CurrentUSD | 42,134,000Source | 39,835,000Source | 35,252,000Source | 33,709,000Source |
| Operating Lease, Liability, NoncurrentUSD | 110,572,000Source | 101,868,000Source | 76,653,000Source | 77,934,000Source |
| Deferred Income Tax Liabilities, NetUSD | 28,391,000Source | 29,465,000Source | 24,815,000Source | 21,303,000Source |
| Other Liabilities, NoncurrentUSD | 3,214,000Source | 18,275,000Source | 2,356,000Source | 13,029,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 456,000Source | 1,092,000Source | 1,216,000Source | 1,260,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 80,982,000Source | 59,513,000Source | 55,344,000Source | 37,413,000Source |
| Deferred Tax Liabilities, NetUSD | 28,391,000Source | 29,465,000Source | 24,815,000Source | 21,303,000Source |
| Long-term Debt, Current MaturitiesUSD | 9,865,000Source | 10,999,000Source | 7,691,000Source | 7,863,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 152,594,000Source | 142,530,000Source | 138,991,000Source | 175,831,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 293,311,000Source | 269,025,000Source | 174,828,000Source | 167,515,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 58,005,000Source | 45,600,000Source | 37,220,000Source | 43,407,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 22,391,000Source | 18,681,000Source | 15,695,000Source | 14,743,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 8,270,000Source | 7,823,000Source | 7,236,000Source | 7,264,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 11,955,000Source | 5,346,000Source | 5,645,000Source | 10,279,000Source |
| Deferred Income Tax Expense (Benefit)USD | 10,599,000Source | 4,874,000Source | 4,648,000Source | 12,416,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 75,058,000Source | 74,940,000Source | 81,978,000Source | 58,537,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 15,674,000Source | 133,087,000Source | 26,582,000Source | 59,788,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -36,713,000Source | -149,450,000Source | -45,015,000Source | -81,269,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | -364,000Source | -694,000Source | -321,000Source | — |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 5,566,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -44,137,000Source | -36,953,000Source | 84,268,000Source | 25,759,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 27,362,000Source | 26,540,000Source | 24,128,000Source | 21,321,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | — | 0Source | 0Source | 12,000Source |
| Repayments of Long-term DebtUSD | 9,375,000Source | 3,750,000Source | 3,750,000Source | 1,875,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -5,792,000Source | -111,463,000Source | 121,231,000Source | 3,027,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 35,570,000Source | 41,362,000Source | 152,825,000Source | 31,594,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 9,431,000Source | 7,209,000Source | 8,655,000Source | 5,687,000Source |
| Income Taxes Paid, NetUSD | 14,348,000Source | 4,832,000Source | 4,926,000Source | 7,615,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 7,200,000Source | — |
| Amortization of Debt Issuance CostsUSD | 422,000Source | 422,000Source | 420,000Source | — |
| Amortization of Intangible AssetsUSD | 11,276,000Source | 9,546,000Source | 7,273,000Source | 6,523,000Source |
| Gain (Loss) on Disposition of BusinessUSD | 100,000Source | — | — | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -383,000Source | -836,000Source | -166,000Source | 643,000Source |
| GoodwillUSD | 692,392,000Source | 667,152,000Source | 509,571,000Source | 494,101,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | 0Source | 0Source | 17,495,000Source | — |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 15,800,000Source | 9,112,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 1,477,000Source | 1,014,000Source | 955,000Source | 1,175,000Source |
| Income Tax Expense (Benefit)USD | 19,808,000Source | 14,609,000Source | 12,156,000Source | 12,164,000Source |
| Investment Income, InterestUSD | 105,000Source | 3,941,000Source | 3,774,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | 39,583,000Source | 31,424,000Source | 28,239,000Source | 32,158,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 18,422,000Source | 14,176,000Source | 8,981,000Source | 11,249,000Source |
| Nonoperating Income (Expense)USD | -8,864,000Source | -3,004,000Source | -2,685,000Source | -1,230,000Source |
| Other Nonoperating Income (Expense)USD | 458,000Source | 357,000Source | 390,000Source | — |
| Payments of Financing CostsUSD | — | 0Source | 0Source | 1,779,000Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 0Source | 163,646,000Source | — |
| Proceeds from Issuance of Long-term DebtUSD | — | 0Source | 0Source | 150,000,000Source |
| Proceeds from Noncontrolling InterestsUSD | 0Source | 1,890,000Source | 4,136,000Source | 1,580,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 780,990,000Source | 671,345,000Source | 604,802,000Source | 553,144,000Source |
| Selling, General and Administrative ExpenseUSD | 69,260,000Source | 58,290,000Source | 51,953,000Source | 46,111,000Source |
| Operating Income (Loss)USD | 86,677,000Source | 63,213,000Source | 52,061,000Source | 56,801,000Source |
| Other Nonoperating Income (Expense)USD | 458,000Source | 357,000Source | 390,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 77,813,000Source | 60,209,000Source | 49,376,000Source | 55,571,000Source |
| Income Tax Expense (Benefit)USD | 19,808,000Source | 14,609,000Source | 12,156,000Source | 12,164,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 18,422,000Source | 14,176,000Source | 8,981,000Source | 11,249,000Source |
| Net Income (Loss) Attributable to ParentUSD | 39,583,000Source | 31,424,000Source | 28,239,000Source | 32,158,000Source |
| Earnings Per Share, BasicUSD per share | 1.42Source | 1.84Source | 1.28Source | 2.25Source |
| Earnings Per Share, DilutedUSD per share | 1.42Source | 1.84Source | 1.28Source | 2.25Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 15,175,000Source | 15,064,000Source | 14,188,000Source | 12,985,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 15,175,000Source | 15,064,000Source | 14,188,000Source | 12,985,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 11,276,000Source | 9,546,000Source | 7,273,000Source | 6,523,000Source |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | 1.8Source | 1.76Source | 1.72Source | 1.64Source |
| Costs and ExpensesUSD | 631,297,000Source | 547,424,000Source | 483,293,000Source | 441,120,000Source |
| Current Income Tax Expense (Benefit)USD | 9,209,000Source | 9,735,000Source | 7,508,000Source | -252,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 21,059,000Source | 17,853,000Source | — | — |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 15,800,000Source | 9,112,000Source |
| Gross ProfitUSD | 149,693,000Source | 123,921,000Source | 121,509,000Source | 112,024,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 1,477,000Source | 1,014,000Source | 955,000Source | 1,175,000Source |
| Interest and Other IncomeUSD | — | — | — | 859,000Source |
| Investment Income, InterestUSD | 105,000Source | 3,941,000Source | 3,774,000Source | — |
| Labor and Related ExpenseUSD | 461,890,000Source | 399,394,000Source | 353,390,000Source | 319,191,000Source |
| Nonoperating Income (Expense)USD | -8,864,000Source | -3,004,000Source | -2,685,000Source | -1,230,000Source |
Filing attachments
ex99-1.htm · 8-K · 2026-09-21
CONTACT: U.S. Physical Therapy, Inc. Nchacha Etta, Chief Financial Officer email: netta@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis Houston, TX, September 21, 2026 - U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-14
EX-99.2 3 ex99-1.htm CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 U.S. Physical Therapy Announces CFO Houston, TX, August 14, 2026 - U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury preve…
Read attachment ↗ex99-1.htm · 8-K · 2026-08-12
EX-99.1 2 ex99-1.htm CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 Disclaimer 2 Forward-Looking Statements This presentation contains forward-looking statements, which involve numerous risks and uncertainties. Included among such statements may be those relating to new clinics, availability of personnel and the …
Read attachment ↗ex99-1.htm · 8-K · 2026-08-10
EX-99.1 2 ex99-1.htm CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 U.S. Physical Therapy August 6, 2026 Earnings Call 10:30 am ET Operator: Good day and thank you for standing by. Welcome to the U.S. Physical Therapy Second Quarter 2026 Earnings Conference Call. At this time, all participants are in a …
Read attachment ↗ex99-1.htm · 8-K · 2026-08-06
EX-99 2 ex99-1.htm Exhibit 99.1 CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Second Quarter 2026 Results, Reaffirms Full Year Guidance Houston, TX, August 5, 2026 - U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and pr…
Read attachment ↗ex99-1.htm · 8-K · 2026-07-06
EX-99.1 2 ex99-1.htm CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 Exhibit 99.1 U.S. Physical Therapy Announces the Acquisition of a Twelve-Clinic Physical Therapy Practice Houston, TX, July 2, 2026 - U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical …
Read attachment ↗